Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden
/
Maarten De Chateau
MD
Maarten De Chateau
Board of Directors, Beactica Therapeutics AB
Thaliavägen 14
SE
12 active roles
Watchlist
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
12 positions
Company
Role
Period
Ownership
Status
Beactica Therapeutics AB
CVR 5567082853
Board
Board of Directors
Since 2021
—
Active
Xintela AB
CVR 5567803480
Board
Board of Directors
Since 2022
—
Active
Sixera Pharma AB
CVR 5569014763
Management
Chief Executive Officer
Since 2020
—
Active
Atrogi AB
CVR 5569258311
Board
Board of Directors
Since 2022
—
Active
Cavis Technologies AB
CVR 5590280607
Board
Board of Directors
Since 2021
—
Dissolved
Chateau Holding AB
CVR 5590438577
Board
Board of Directors
Since 2020
—
Active
Cordivest AB
CVR 5590665401
Board
Board of Directors
Since 2022
—
Active
Buzzard Pharmaceuticals AB
CVR 5590736855
Board
Board of Directors
Since 2020
—
Active
Saare Consulting AB
CVR 5591171474
Board
Deputy Board Member
Since 2022
—
Active
Targinta AB
CVR 5591576698
Board
Board of Directors
Since 2022
—
Active
MetaCurUm Biotech AB
CVR 5591636393
Board
Board of Directors
Since 2022
—
Active
Maarten De Chateau
CVR 6306209377
Other
Stakeholder
Since 2023
—
Active
Historical roles
3 positions
Company
Role
Period
Ownership
Status
OxThera AB
CVR 5566815667
Board
Board of Directors
2020 – 2021
—
Active
Gesynta Pharma AB
CVR 5591036628
Board
Board of Directors
2020 – 2021
—
Active
Strike Pharma AB
CVR 5592842651
Board
Board of Directors
2022 – 2023
—
Active
More on Maarten De Chateau
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities